Objective To explore the clinical efficacy of ginseng polysaccharides combined GP regimen for treatment of non-small cell lung cancer. Methods 80 cases of patients with non-small cell lung cancer received in our hospital from Jan 2011 to Jun 2012 were divided into observation group and control group according to the treated order, with 40 cases in each group. The control group was received chemotherapy GP(gemcitabine + cisplatin); the observation group were given ginseng polysaccharide injection based on the control group, the efficacy, toxicity and survival rates in the two groups of patients were compared. ResultsThe total effective rate in observation group was 60%, significantly better than the control group(45%), the difference was statistically significant(x2=4.511,P0.05); The incidence of decreased leukopenia, thrombocytopenia, anemia, gastrointestinal damage and alopecia in observation group were significantly lower than the control group, the difference was statistically significant(x2=14.25,12.53,4.604,7.031,4.945,P0.05); One year survival rate in observation group was 65%, there was no significant difference compared with the control group(55%, P0.05). Conclusion Ginseng polysaccharide combined GP regimen for the treatment of non-small cell lung cancer had significant efficacy and fewer side effects, worthy of promotion.